Biolife Solutions (BLFS) Notes Payables (2016 - 2020)
Biolife Solutions' (BLFS) quarterly Notes Payables came in at $2.8 million in Q4 2020, up 45.25% quarter-over-quarter from $1.9 million in Q3 2020.
Analysis
Biolife Solutions (BLFS) Notes Payables (2016 - 2020) Analysis & Trends
Biolife Solutions (BLFS) has reported Notes Payables for 2 consecutive years, with $2.8 million the latest figure, recorded in Q4 2020.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $2.8 million in Q4 2020; TTM through Dec 2020 was $2.8 million, a N/A change from a year earlier, with the FY2020 full-year figure at $2.8 million, changed N/A from the prior year.
- Notes Payables was $2.8 million for Q4 2020 at Biolife Solutions, up from $1.9 million in the prior quarter.
- Over five years, Notes Payables peaked at $17.7 million in Q1 2020 and troughed at $656809.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn |
| 10 | Biolife Solutions | 1.71 Bn | 1.62 Bn | 18.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 2.78 Mn |
| Sep 30, 2020 | 1.91 Mn |
| Jun 30, 2020 | 963,000.00 |
| Mar 31, 2020 | 17.67 Mn |
| Dec 31, 2016 | 2.84 Mn |
| Sep 30, 2016 | 1.75 Mn |
| Jun 30, 2016 | 656,809.00 |